Media

News

06 Apr 2020

HLL Lifecare Limited, a Central Government Enterprise under Ministry of Health and

Family Welfare has developed the rapid antibody diagnostic kit for COVID 19. The kit is

one-step novel Corona virus (COVID 19) IgM/IgG Antibody detection from the human

serum, plasma and/or whole blood obtained from the patient with signs and symptoms of

respiratory infection.

The kit manufactured at HLL’s rapid diagnostic kit manufacturing facility in Manesar,

Gurgaon, Haryana has been validated and approved by NIV Pune and ICMR for use in

India.

This device is designed to aid in the rapid differential diagnosis of COVID -19 virus

infection in large population screening in our country during the current pandemic situation

and this shall support in the management of control and treatment of Corona virus

disease. The test result can be obtained from the patient sample within 15-20

minutes. HLL is the first Indian Government company received the approval from ICMR

for manufacturing and supplying the Rapid Antibody kit for COVID-19 detection.

The kit manufactured by HLL will be marketed under the brand name of “MakeSure” -

Covid IgM/IgG Antibody detection.

The principle of “Makesure” Covid-19 IgM/IgG Antibody test kit is based on Antibody

capture immunochromatographic assay for the simultaneous detection of IgM & IgG

antibodies to COVID-19 virus in human serum, plasma and/or whole blood samples.

HLL is planning to manufacture 2.0 lakh kits for supplying to various Government units

with in next 10 days. HLL is also planning to develop and manufacture Viral Transport

Medium which is in short supply in the country, as the molecular test volume pick up will

be required in huge quantities. HLL also started manufacturing hand sanitizer, “Medigard”

from its manufacturing facilities in Peroorkkada, Trivandrum and Belgaum , Karnataka

factories.